Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments-Reference-Cited by-同舟云学术

Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments

Published:2017-02 Issue:2 Volume:39 Page:359-367
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Agarwal Suresh K.,DiNardo Courtney D.,Potluri Jalaja,Dunbar Martin,Kantarjian Hagop M.,Humerickhouse Rod A.,Wong Shekman L.,Menon Rajeev M.,Konopleva Marina Y.,Salem Ahmed Hamed

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets;Souers;Nat Med,2013

2. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia;Roberts;N Engl J Med,2016

3. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study;Stilgenbauer;Lancet Oncol,2016

4. Davids MS, Roberts AW, Seymour JF, et al. Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-Hodgkin lymphoma. J Clin Oncol. [published online January 17, 2017]; http://dx.doi.org/10.1200/JCO.2016.70.4320.

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for posaconazole therapeutic drug monitoring and their clinical benefits;European Journal of Clinical Pharmacology;2024-09-09

2. Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study;Annals of Hematology;2024-08-29

3. Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia;Expert Review of Hematology;2024-08-12

4. Ven the dose matters: Venetoclax dosing in the frontline treatment of AML;Blood Reviews;2024-08

5. How can we optimize antifungal use and stewardship in the treatment of acute leukemia?;Expert Review of Hematology;2024-07-25